HF
VYNT

HRT Financial’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

HRT Financial’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,911
Closed -$11K – 3487
2022
Q4 		$11K Buy
+16,911
New +$27.5K ﹤0.01% 2220
2018
Q2 		– Sell
-175
Closed -$43K – 388
2018
Q1 		$43K Buy
175
+20
+13% +$5.63K 0.02% 187
2017
Q4 		$42K Buy
155
+53
+52% +$20.2K 0.04% 105
2017
Q3 		$41K Buy
+102
New +$53.2K 0.05% 95

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's VYNT Position: Q1 2023 in Review

HRT Financial sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2023, closing a stake of 16,911 shares — an estimated $11K sold.

HRT Financial first reported a position in VYNT in Q3 2017 and held it in 4 quarters. The position peaked at $43K in Q1 2018. 17 funds tracked by Wall St. Rank hold VYNT as of Q1 2023.

  • HRT Financial reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 16,911 Vyant Bio, Inc. Common Stock shares in Q1 2023, an estimated $11K.
  • HRT Financial first reported a position in Vyant Bio, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • HRT Financial's Vyant Bio, Inc. Common Stock position peaked at $43K in Q1 2018.
  • 17 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.